Table 3.
Outcome measures
| Outcome measures | Timeline | ||
|---|---|---|---|
| Pre-intervention | Post-intervention | ||
| 3 mo | 12 mo | ||
| 1. Socio-demographic variables | |||
| Sex, age, marital status, educational level, employment status, reference PHC | X | ||
| 2. Diagnostic variables | |||
| Diagnosis depression: MINI | X | ||
| Diagnosis chronic physical illness: ICD-10 | X | ||
| Suicide risk: MINI | X | ||
| Cognitive impairment: Pfeiffer questionnaire | X | ||
| 3. Clinical variables | |||
| Depressive symptoms: BDI- II questionnaire | X | X | X |
| Anxiety symptoms: HARS questionnaire | X | X | X |
| Quality of life: EQ-5D-5 L questionnaire | X | X | X |
| Pharmacotherapy | X | X | X |
| Therapeutic compliance: Morinsky-Green test | X | X | X |
| Feasibility of the intervention | X | X | |
| 4. Blood test and Physical parameters | |||
| Type 2 diabetes mellitus: Analytical HBA1C | X | X | |
| COPD: FEV1 and Medical Research Coincil (mMRC) | X | X | |
| Asthma: Spirometry and Peak flow | X | X | |
| Ischemic heart disease: Analytical cholesterol LDL and Blood pressure | X | X | |
| 5. Costs variables | |||
| Pharmacological Treatment | X | X | X |
| Utilization of services: PHC and hospital | X | X | X |
| Other comorbidities | X | X | |
| Costs derived from the intervention | X | X | X |
Abbreviations: mo months, BDI-II Beck Depression Inventory secondary edition, COPD Chronic obstructive pulmonary disease, EQ EuroQuol, FEV1 Forced expiratory volume, HARS Hamilton Anxiety Rating Scale, HBA1C Hemoglobin A1C test, ICS-10 International classification of diseases-10th revision, MINI Mini international neuropsychiatric interview, PHC Primary Healthcare Centers